Treatments For Sarcoidosis

Clinical Trials

Due to limited treatment options, there are often clinical trials available to patients who qualify. Those who are of adult age might qualify for a medication combination currently being tested, which includes Levaquin, azithromycin, ethambutol, and rifampin. This trial is targeted at those with progressive lung symptoms. Those who do not use nicotine products and are adults might qualify for a study looking to see if nicotine patches might be a way to treat this condition. It is important for patients to have no nicotine in their system, and it may also require no history of nicotine use to ensure the results are accurate. A third study is for those aged eighteen or those who are NIH patients and at least sixteen. This research is aimed at looking for specific genes potentially associated with the lung issues of sarcoidosis. The hope is to target the genes and then find a treatment that can be targeted to alleviate the lung involvement with this disease.

Continue for the next treatment for sarcoidosis.